메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

SNC and Applied Intuition Forge Alliance to Fast-track Battlefiel…

[ 메디채널 김갑성 기자 ] Collaboration will fuse rapid software innovation with combat-tested systems integration to outpace global rivals MOUNTAIN VIEW, Calif. and SPARKS, Nev., Dec. 2, 2025 -- In a move signaling how quickly autonomous systems are reshaping modern warfare, physical intelligence leader Applied Intuition and global aerospace and defense company SNC today announced a partnership aimed at accelerating delivery of next-generation autonomous defense technologies. Everything that moves is quickly gaining autonomy – especially on the battlefield – and Applied Intuition is cr
- 김갑성 기자
- 2025-12-02 22:00
Yuyu Pharma Announces Strategic Investment in Dalan Anima…

SEOUL, South Korea, Dec. 2, 2025 -- Yuyu Pharma announced today that it has completed a strategic investment in Dalan Animal Health, a U.S.-based biotechnology company advancing an innate immunity–based platform for developing vaccines for honeybees and shrimp. The investment marks a significant step in Yuyu Pharma's plan to become a more active global player in the fast-growing animal health sector. Dalan is recognized for delivering the world's first USDA-approved honeybee vaccine and is now advancing a first-in-class shrimp vaccine aimed at transforming disease
- 김갑성 기자
- 2025-12-02 22:00
L&C Bio's 'Re2O' Emerges as a Leading K-Medical Tour Proc…

[ 메디채널 김갑성 기자 ] – Surging global demand drives rapid adoption across domestic and international medical sectors – SEONGNAM, South Korea, Dec. 2, 2025 -- L&C Bio (KOSDAQ: 290650, Co-CEOs Hwan-Chul Lee and Jae-Ho Lee), a leading company in human tissue–based regenerative medicine, announced that its premium regenerative solution Re2O (ReCM, ECM: Extra Cellular Matrix) has rapidly emerged as a signature K-Medical tour procedure among international customers within just one year of its launch. Re2O is demonstrating robust sales growth and rapidly expanding its market presence among i
- 김갑성 기자
- 2025-12-02 22:00
Neurophet Appoints Josh Cohen, Former Executive from a Glo…

Expert in sales and commercial strategy…Ex-Philips and previously served as Chief Commercial Officer (CCO) at Cortechs.ai To strengthen revenue growth of AI-based brain imaging solutions in the North American market and expand product deployment across healthcare institutions SEOUL, South Korea, Dec. 2, 2025 -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced on 2nd that it has appointed Josh Cohen, a veteran executive from leading global medical device companie
- 김갑성 기자
- 2025-12-02 22:00
Nature Communications | Insilico Medicine Presents AI-emp…

[ 메디채널 김갑성 기자 ] AI Designs a Novel RPOTAC from Scratch: Insilico's generative AI platform, Chemistry42, successfully designed a first-in-class PROTAC targeting PKMYT1 by creating an entirely new inhibitor and its complex linker, demonstrating a powerful, end-to-end approach to new modality drug discovery. A Superior Dual-Action Mechanism: The novel PROTAC, D16-M1P2, employs a powerful dual-action mechanism that simultaneously degrades and inhibits the cancer-driving PKMYT1 protein, resulting in a more potent, selective, and durable therapeutic effect than traditional inhibitors. Strong P
- 김갑성 기자
- 2025-12-02 22:00
Kazia Therapeutics Announces Pricing of $50.0 Million Priva…

SYDNEY, Dec. 2, 2025 -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced that it has entered into a securities purchase agreement with certain established institutional and accredited investors for a private placement of equity securities (PIPE). Pursuant to the securities purchase agreement, the Company agreed to offer and sell to the investors an aggregate of approximately $50.0 million of ordinary shares and prefunded warrants, at a purchase price per share that is the equivalent of $5.00 per ADS, each ADS representing 500 ordinary sh
- 김갑성 기자
- 2025-12-02 22:00
SNC と Applied Intuition 、戦場自律化を加速させるための提携を締結

[ 메디채널 김갑성 기자 ] 協業を通じた迅速なソフトウェア革新と実戦検証済みのシステム統合融合により、グローバル競争の先頭に立つカリフォルニア州マウンテンビューおよびネバダ州スパークス, 2025年12月2日 -- 自律システムが現代の戦争形態をいかに急速に変革しているかを示す動きとして、物理知能分野のリーダーである Applied Intuition と、グローバルな航空宇宙・防衛企業 SNC は本日、次世代自律防衛技術の提供加速を目的とした提携を発表しました。あらゆる移動体が急速に自律化を進めている (特に戦場において) 中、 Applied Intuition は最前線の全移動機械に知能をもたらすためのデジタル基盤を構築しています。シリコンバレー企業である同社のデュアルユース自律ソフトウェア技術と、SNC が長年培ってきた信頼性の高いオープンアーキテクチャ任務システムの開発・統合ノウハウが融合し、迅速なイノベーションと運用準備態勢の必要性をつなぐ架け橋となります。本提携は、戦闘要員が任務遂行可能な自律技術をより迅速に活用することを目指します。両社は、 Applied Intuition の先進的な自律・シミュレーションソフトウェアと、SNC が各領域で実戦検証済みの多様なミッションシステムを統合する主要な機会を共
- 김갑성 기자
- 2025-12-02 22:00
SNC와 Applied Intuition, 전장 자율화 가속화를 위한 동맹 체결

[ 메디채널 김갑성 기자 ] 협력을 통한 신속한 소프트웨어 혁신과 실전 검증된 시스템 통합 융합으로 글로벌 경쟁의 선두를 차지 캘리포니아주 마운틴뷰와 네바다주 스파크스, 2025년 12월 2일 -- 자율 시스템이 현대 전쟁을 재편하는 속도를 보여주는 움직임의 일환으로, 물리적 인텔리전스 분야의 선도 기업 Applied Intuition과 글로벌 항공우주 및 방산 기업 SNC는 오늘 차세대 자율 방어 기술의 신속한 공급을 목표로 한 파트너십을 발표했습니다. 움직이는 모든 것, 특히 전장에서 움직이는 것들은 빠르게 자율성을 획득하고 있으며, Applied Intuition은 전선에서 움직이는 모든 기계에 지능(intelligence) 을 부여하는 데 필요한 디지털 인프라를 구축하고 있습니다. 실리콘밸리 기업의 듀얼유스 자율 소프트웨어 전문성은 SNC의 오랜 신뢰받는 개방형 아키텍처 임무 시스템 개발 및 통합 역량과 결합되어 신속한 혁신과 작전 준비 태세 사이의 가교 역할을 할 것입니다. 이번 협력은 전투원에게 임무 수행 가능한 자율 시스템을 더 빠르게 제공하기 위한 것으로 양사는 Applied Intuition의 선
- 김갑성 기자
- 2025-12-02 22:00
Frost & Sullivan: Health Recovery Solutions Receives the 2025…

[ 메디채널 김갑성 기자 ] Frost & Sullivan recognizes Health Recovery Solutions for delivering adaptable, outcomes-driven, technology-enabled longitudinal care models SAN ANTONIO, Dec. 2, 2025 -- Frost & Sullivan is pleased to announce that Health Recovery Solutions (HRS) has received the 2025 North American Customer Value Leadership Recognition in the longitudinal care models sector for its outstanding achievements in system efficiency, sustainable program outcomes, and long-term client value. This recognition highlights HRS's consistent leadership in delivering measurable improvement
- 김갑성 기자
- 2025-12-02 21:30
Health In Tech Announces Voluntary Extension of Lock-Up…

STUART, Fla., Dec. 2, 2025 -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced that its executive management team, vice presidents across functions, and Board of Directors have voluntarily agreed to extend the lock-up restrictions on all shares they hold for an additional six months beyond the original twelve-month lock-up established at the time of the Company's final prospectus issued in connection with its initial public offering on December 20, 2024. Under this voluntary extension, all shares hel
- 김갑성 기자
- 2025-12-02 21:00

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2025-12-10_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 12월 10일 20시 40분